Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,741 | 82 | 94.6% |
| Education | $99.00 | 1 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $292.24 | 11 | $0 (2019) |
| Amgen Inc. | $216.42 | 5 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $209.68 | 18 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $193.29 | 9 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $160.63 | 6 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $153.79 | 9 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $130.37 | 3 | $0 (2017) |
| PFIZER INC. | $125.93 | 4 | $0 (2018) |
| Boston Scientific Corporation | $88.65 | 1 | $0 (2020) |
| Lundbeck LLC | $34.91 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $88.65 | 1 | Boston Scientific Corporation ($88.65) |
| 2019 | $217.92 | 6 | Amgen Inc. ($142.25) |
| 2018 | $397.49 | 8 | Janssen Pharmaceuticals, Inc ($136.96) |
| 2017 | $1,136 | 68 | AstraZeneca Pharmaceuticals LP ($177.34) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $88.65 | General |
| Category: STRUCTURAL HEART | ||||||
| 10/28/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Cardiology | ||||||
| 06/24/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.13 | General |
| 04/22/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $121.75 | General |
| Category: Cardiology | ||||||
| 03/01/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.04 | General |
| Category: Cardiovascular | ||||||
| 02/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Cardiovascular | ||||||
| 11/28/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: Cardiology | ||||||
| 11/14/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $92.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $81.70 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/09/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/22/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/01/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.63 | General |
| Category: Cardiovascular | ||||||
| 01/25/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $108.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.54 | General |
| Category: Cardiovascular | ||||||
| 12/11/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $97.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.41 | General |
| Category: Cardiovascular | ||||||
| 11/15/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.40 | General |
| Category: Cardiovascular | ||||||
| 11/03/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.23 | General |
| Category: Cardiovascular | ||||||
| 10/26/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.49 | General |
| Category: Cardiovascular | ||||||
| 09/29/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/26/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/26/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,344 | 1,797 | $729,077 | $154,664 |
| 2022 | 18 | 1,165 | 1,652 | $616,122 | $145,769 |
| 2021 | 19 | 1,368 | 1,900 | $707,440 | $173,550 |
| 2020 | 18 | 1,267 | 1,752 | $688,610 | $153,901 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 305 | 487 | $130,516 | $46,465 | 35.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 211 | 212 | $225,780 | $32,721 | 14.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 58 | 58 | $71,572 | $22,141 | 30.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 58 | 116 | $54,392 | $11,086 | 20.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 41 | 164 | $17,876 | $7,279 | 40.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 69 | $18,216 | $6,868 | 37.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 79 | $14,536 | $5,259 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 60 | $10,920 | $4,315 | 39.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 69 | 69 | $28,221 | $3,688 | 13.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 58 | 58 | $67,156 | $3,211 | 4.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 243 | 263 | $23,670 | $3,009 | 12.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $8,991 | $2,903 | 32.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 29 | 29 | $14,848 | $1,671 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,980 | $1,651 | 33.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,896 | $1,602 | 32.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 28 | 29 | $26,968 | $603.78 | 2.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 21 | 21 | $3,616 | $126.00 | 3.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 26 | 26 | $1,923 | $66.36 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 281 | 493 | $132,124 | $47,642 | 36.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 162 | 163 | $173,595 | $27,697 | 16.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 45 | 45 | $55,530 | $17,962 | 32.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 45 | 90 | $32,850 | $9,026 | 27.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 129 | $23,736 | $7,655 | 32.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 33 | 132 | $14,388 | $6,410 | 44.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 57 | $15,048 | $4,942 | 32.8% |
About Dr. Gregory Bloom, MD
Dr. Gregory Bloom, MD is a Cardiovascular Disease healthcare provider based in Trumbull, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1316088248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Bloom, MD has received a total of $1,840 in payments from pharmaceutical and medical device companies, with $88.65 received in 2020. These payments were reported across 83 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,741).
As a Medicare-enrolled provider, Bloom has provided services to 5,144 Medicare beneficiaries, totaling 7,101 services with total Medicare billing of $627,885. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology
- Location Trumbull, CT
- Active Since 02/12/2007
- Last Updated 03/07/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1316088248
Products in Payments
- ELIQUIS (Drug) $324.67
- XARELTO (Drug) $292.24
- BRILINTA (Drug) $193.29
- Repatha (Biological) $172.98
- LifeVest (Device) $160.63
- PRADAXA (Drug) $153.79
- PRALUENT (Drug) $130.37
- WATCHMAN (Device) $88.65
- Corlanor (Drug) $43.44
- NORTHERA (Drug) $34.91
- Livalo (Drug) $26.34
- KENGREAL (Drug) $24.75
- BYSTOLIC (Drug) $23.46
- Savaysa (Drug) $22.32
- Lexiscan (Drug) $19.00
- Adempas (Drug) $17.98
- PRALUENT ALIROCUMAB INJECTION (Biological) $17.24
- CardioMEMS HF System (Device) $16.64
- Veltassa (Drug) $14.84
- ENTRESTO (Drug) $14.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Trumbull
Dr. Manuel Pun, Md, MD
Cardiovascular Disease — Payments: $43,941
Dr. Robert Jumper, Md, MD
Cardiovascular Disease — Payments: $15,657
David Lorenz, M.d, M.D
Cardiovascular Disease — Payments: $15,579
Dr. Charles Landau, Md, MD
Cardiovascular Disease — Payments: $7,204
Victor Mejia, M.d, M.D
Cardiovascular Disease — Payments: $6,852
Dr. Jeffrey Berman, M.d, M.D
Cardiovascular Disease — Payments: $3,299